NYSE:SBS • US20441A1025
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CIA SANEAMENTO BASICO DE-ADR (SBS).
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 22.056B 13.16% | 25.572B 15.94% | 36.145B 41.35% | 23.636B -34.61% | 26.506B 12.14% | 31.001B 16.96% | 35.118B 13.28% | 38.774B 10.41% | 41.624B 7.35% | |
| EBITDA YoY % growth | 7.071B 11.73% | 9.104B 28.75% | 18.152B 99.38% | 13.715B -24.44% | 16.415B 19.69% | 21.127B 28.71% | 21.228B 0.48% | 27.888B 31.37% | 29.325B 5.15% | |
| EBIT YoY % growth | 4.621B 13.38% | 6.314B 36.64% | 15.475B 145.11% | 11.754B -24.05% | 14.128B 20.20% | 18.463B 30.68% | 19.959B 8.10% | 21.503B 7.74% | 25.664B 19.35% | |
| Operating Margin | 20.95% | 24.69% | 42.81% | 49.73% | 53.30% | 59.56% | 56.83% | 55.46% | 61.66% | |
| EPS YoY % growth | 4.45 35.31% | 5.04 13.16% | 13.67 171.50% | 11.07 -19.05% | 10.55 -4.69% | 14.27 35.27% | N/A | N/A | N/A |
All data in BRL
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.64 28.75% | 2.35 10.94% | 2.47 -18.76% | 2.60 -15.76% | 2.00 -24.27% | 1.51 -35.68% | 1.20 -51.46% | 1.52 -41.43% | 2.34 17.10% | 1.66 9.59% | 1.33 10.34% |
| Revenue Q2Q % growth | 5.934B -24.30% | 6.757B -19.81% | 6.749B -24.71% | 6.714B -28.76% | 7.089B 19.46% | 8.016B 18.63% | 8.077B 19.68% | 8.139B 21.22% | 8.201B 15.69% | N/A | N/A |
| EBITDA Q2Q % growth | 3.431B -22.73% | 3.821B 11.85% | 4.053B -9.12% | 4.138B 23.78% | 3.859B 12.47% | 3.972B 3.95% | 3.623B -10.61% | 4.126B -0.29% | 4.423B 14.62% | 4.467B 12.46% | 4.075B 12.48% |
| EBIT Q2Q % growth | 2.975B 68.66% | 3.52B 24.27% | 3.579B 7.38% | 3.631B 21.44% | 4.173B 40.27% | 5.031B 42.93% | 5.057B 41.30% | 5.083B 39.99% | 5.111B 22.48% | N/A | N/A |
All data in BRL
20 analysts have analysed SBS and the average price target is 29.44 USD. This implies a price increase of 5.76% is expected in the next year compared to the current price of 27.84.
CIA SANEAMENTO BASICO DE-ADR (SBS) will report earnings on 2026-05-07.
The consensus EPS estimate for the next earnings of CIA SANEAMENTO BASICO DE-ADR (SBS) is 2.64 USD and the consensus revenue estimate is 5.93B USD.
The consensus rating for CIA SANEAMENTO BASICO DE-ADR (SBS) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.